European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Traditional Chinese Medicine in the Post-genomic era: identifying lead therapeutic compounds against cancer

Cel

This application aims at identifying and characterizing a set of lead therapeutic compounds against cancer (breast, lung and brain), based on current knowledge from Traditional Chinese Medicine (TCM). TCM has a very long tradition in the prevention and treatment of a variety of diseases yet, in contrast to target-oriented Western medicine, TCM uses a holistic and synergistic approach, which can be very effective for complex medical problems. However, the exact composition of the compounds that exert the therapeutic effect is not known. As there is little understanding about the mechanisms of action of many TCM therapies, modern and multidisciplinary Biotech research (functional genomics/ systems biology) should be applied on appropriate and highly defined cancer models. The presented project will focus on the isolation and characterization of chemical compounds from TCM that show anti-tumoral efficacy. From a library of therapeutic compounds available, a set of lead therapeutic substances will be identified using high throughput screening technologies in appropriate preclinical cancer models. Moreover, their mechanism of action will be further studied using genome wide analyses. Finally, their therapeutic efficacy will be tested in appropriate animal models.

Zaproszenie do składania wniosków

FP7-PEOPLE-IRSES-2008
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

LUXEMBOURG INSTITUTE OF HEALTH
Wkład UE
€ 237 600,00
Adres
1A RUE RUE THOMAS EDISON
1445 Strassen
Luksemburg

Zobacz na mapie

Region
Luxembourg Luxembourg Luxembourg
Rodzaj działalności
Research Organisations
Kontakt administracyjny
Daniel Cardao (Mr.)
Linki
Koszt całkowity
Brak danych